These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 6443609

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Postlabeling methods for carcinogen-DNA adduct analysis.
    Randerath K, Randerath E, Agrawal HP, Gupta RC, Schurdak ME, Reddy MV.
    Environ Health Perspect; 1985 Oct; 62():57-65. PubMed ID: 3910421
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Monitoring carcinogen actions on DNA by 32P-postlabeling.
    Randerath K, Randerath E.
    Princess Takamatsu Symp; 1990 Oct; 21():317-28. PubMed ID: 2134685
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Enhanced sensitivity of 32P-postlabeling analysis of aromatic carcinogen:DNA adducts.
    Gupta RC.
    Cancer Res; 1985 Nov; 45(11 Pt 2):5656-62. PubMed ID: 4053037
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparative 32P-analysis of cigarette smoke-induced DNA damage in human tissues and mouse skin.
    Randerath E, Avitts TA, Reddy MV, Miller RH, Everson RB, Randerath K.
    Cancer Res; 1986 Nov; 46(11):5869-77. PubMed ID: 3756927
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. 32P-Post-labelling method improvements for aromatic compound-related molecular epidemiology studies.
    Munnia A, Saletta F, Allione A, Piro S, Confortini M, Matullo G, Peluso M.
    Mutagenesis; 2007 Nov; 22(6):381-5. PubMed ID: 17716983
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Improvements in the 32P-postlabelling procedure to quantify bulky aromatic DNA adducts.
    Steenwinkel MJ, Roggeband R, van Delft JH, Baan RA.
    IARC Sci Publ; 1993 Nov; (124):65-70. PubMed ID: 7693587
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Methods for testing compounds for DNA adduct formation.
    Reddy MV.
    Regul Toxicol Pharmacol; 2000 Dec; 32(3):256-63. PubMed ID: 11162719
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. 32P-postlabeling test for covalent DNA binding of chemicals in vivo: application to a variety of aromatic carcinogens and methylating agents.
    Reddy MV, Gupta RC, Randerath E, Randerath K.
    Carcinogenesis; 1984 Feb; 5(2):231-43. PubMed ID: 6697441
    [Abstract] [Full Text] [Related]

  • 20. Recovery of bulky DNA adducts by the regular and a modified 32P-postlabelling assay; influence of the DNA-isolation method.
    Kovács K, Anna L, Rudnai P, Schoket B.
    Mutat Res; 2011 Mar 18; 721(1):95-100. PubMed ID: 21237286
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.